Super Vidalista is a combination medication used to treat both erectile dysfunction (ED) and premature ejaculation (PE). It contains two active ingredients: tadalafil (20 mg) and dapoxetine (60 mg). Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used to treat ED, while dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat PE.

While Super Vidalista can be taken on an as-needed basis before sexual activity, it is not typically recommended for daily use. Here's why:

Tadalafil (the ED component): Tadalafil, the PDE5 inhibitor in Super Vidalista, is available in lower doses (2.5 mg to 5 mg) for daily use in the treatment of ED. However, the dosage of tadalafil in Super Vidalista (20 mg) is higher and intended for occasional use, typically taken before anticipated sexual activity.

Dapoxetine (the PE component): Dapoxetine, the SSRI in Super Vidalista, is not approved for daily use. It is intended to be taken on an as-needed basis, usually 1 to 3 hours before sexual activity, to help delay ejaculation and improve control over ejaculation.

Taking Super Vidalista daily may increase the risk of side effects and complications associated with both tadalafil and dapoxetine. Additionally, daily use of the medication may lead to tolerance and decreased effectiveness over time.

If you experience ED or PE on a daily basis and are considering treatment, it's essential to discuss your options with a healthcare provider. They can recommend a suitable treatment plan based on your individual needs, health history, and treatment goals. This may include daily use of lower-dose tadalafil for ED or other medications for PE, depending on the specific circumstances.